Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ALT | PRESS-RELEASE | bullish | 7/10 | Altimmune presented new 48-week data from the IMPACT Phase 2b trial of pemvidutide in MASH at the EASL Congress 2026. Th | May 28, 2026 |
| PHARM | PRESS-RELEASE | neutral | 2/10 | Pharming Group announced that shareholders approved all proposals at its 2026 Annual General Meeting, including the appo | May 28, 2026 |
| PMN | PRESS-RELEASE | neutral | 3/10 | ProMIS Neurosciences announced participation in five June 2026 investor conferences and reiterated its timeline for the | May 28, 2026 |
| AKTX | PRESS-RELEASE | neutral | 4/10 | Akari Therapeutics announced CEO participation in a Virtual Investor interview discussing its first ASCO abstract accept | May 28, 2026 |
| PGNY | PRESS-RELEASE | bearish | 6/10 | Progyny reported Q1 2026 EPS of $0.29 on revenue of $348.6M, sharply below consensus estimates of $0.52 and $348.6M resp | May 28, 2026 |
| INKT | PRESS-RELEASE | neutral | 4/10 | MiNK Therapeutics announced first patient dosing in a randomized Phase 2 trial (C-1300-02) evaluating agenT-797 for seve | May 28, 2026 |
| SAM | PRESS-RELEASE | neutral | 2/10 | Samuel Adams (Boston Beer) announced a summer 2026 limited-edition Brewer Patriot Collection and Star Spangled Variety P | May 28, 2026 |
| GMM | PRESS-RELEASE | neutral | 3/10 | Global Mofy AI announced a cooperation with Amazon Web Services (AWS) for cloud deployment of its digital asset library | May 28, 2026 |
| LUD | PRESS-RELEASE | neutral | 3/10 | Luda Technology acquired a 4% equity interest in Hong Kong International New Economic Research Institute Limited (INERI) | May 28, 2026 |
| YQ | PRESS-RELEASE | neutral | 3/10 | 17 Education & Technology Group announced the dismissal of Deloitte as its auditor and the appointment of Marcum Asia, e | May 28, 2026 |
| TORO | PRESS-RELEASE | bearish | 6/10 | Toro Corp. reported Q1 2026 revenue of $6.0M (+9.1% YoY) but net income from continuing operations fell 66.7% to $0.5M, | May 28, 2026 |
| SHIP | PRESS-RELEASE | bullish | 7/10 | Seanergy Maritime reported a strong Q1 2026 beat with GAAP EPS of $0.45 (vs $0.39 consensus) and net revenues of $42.9M | May 28, 2026 |
| ENTX | PRESS-RELEASE | bullish | 6/10 | Entera Bio announced that multiple abstracts across its oral peptide pipeline were accepted for ENDO 2026, with new clin | May 28, 2026 |
| MIMI | PRESS-RELEASE | neutral | 4/10 | Mint Inc Ltd announced a joint venture with Rice Robotics to form Rice Robotics AGI, contributing HK$15M (~$1.9M) for a | May 28, 2026 |
| SPRC | PRESS-RELEASE | neutral | 4/10 | SciSparc announced that its majority-owned subsidiary NeuroThera received conditional TSX approval for the acquisition o | May 28, 2026 |
| DSX | PRESS-RELEASE | neutral | 4/10 | Diana Shipping reported Q1 2026 net income of $29.1M ($0.25 EPS) vs $3.0M ($0.01 EPS) in Q1 2025, driven by a $26.4M gai | May 28, 2026 |
| HUHU | PRESS-RELEASE | bullish | 5/10 | HUHUTECH International Group announced a $936,000 follow-on contract from a leading U.S. semiconductor foundry for its A | May 28, 2026 |
| LAES | PRESS-RELEASE | neutral | 4/10 | SEALSQ announced that its QS7001 Post-Quantum Secure Element received NIST Entropy Source Validation (ESV) Certificate # | May 28, 2026 |
| PLYX | PRESS-RELEASE | mixed | 6/10 | Polaryx Therapeutics closed a $10M PIPE financing at ~$4.00/share, issuing 2.5M new shares. Proceeds will fund the Phase | May 28, 2026 |
| SWAG | PRESS-RELEASE | neutral | 3/10 | Stran & Company announced multiple new contract wins in the consumer retail vertical, including a three-year uniform pro | May 28, 2026 |
| BMRA | PRESS-RELEASE | bullish | 6/10 | Biomerica entered a Master Services Agreement with a confidential life sciences company to develop proprietary IVD assay | May 28, 2026 |
| FORTY | PRESS-RELEASE | bullish | 7/10 | Formula Systems reported record Q1 2025 results with revenue of $738.3M (+19.2% YoY) and net income of $35.6M (+84.5% Yo | May 28, 2026 |
| TDTH | PRESS-RELEASE | neutral | 4/10 | Trident Digital Tech Holdings (TDTH) announced a binding LOI to acquire an equity stake in Digital Innovations Group and | May 28, 2026 |
| ALAR | PRESS-RELEASE | bullish | 6/10 | Alarum reported Q1 2026 revenue of $11.7M (+64% YoY) and GAAP EPS of $0.03, beating the $0.02 consensus. The company gui | May 28, 2026 |
| NEOV | PRESS-RELEASE | bearish | 6/10 | NeoVolta priced a public offering of 12.2M shares at $2.05/share, expecting ~$25M in gross proceeds. The offering repres | May 28, 2026 |
| NEOV | PRESS-RELEASE | bullish | 6/10 | NeoVolta announced a non-binding Letter of Intent with strategic investor Infinite Grid Capital for up to ~1.1 GWh of ut | May 28, 2026 |
| COGT | PRESS-RELEASE | bullish | 8/10 | Cogent Biosciences announced FDA acceptance of its NDA for bezuclastinib in combination with sunitinib for GIST, with Pr | May 28, 2026 |
| SLGL | PRESS-RELEASE | neutral | 5/10 | Revenue fell to $0.1M from $1.0M on a prior-year milestone payment. The company raised $33.1M in an oversubscribed offer | May 28, 2026 |
| NAT | PRESS-RELEASE | neutral | 4/10 | Nordic American Tankers declared a $0.22 per share dividend for Q1 2026, its 115th consecutive quarterly payout. The com | May 28, 2026 |
| BOSC | PRESS-RELEASE | bearish | 6/10 | BOSC reported Q1 2026 revenue of $11.4M (down 24% YoY from $15.0M, which included a $2.5M outsized transaction) and GAAP | May 28, 2026 |